Instituto Rosenbusch S.A. (BCBA:ROSE)

Argentina · Delayed Price · Currency is ARS

156.00

-4.00 (-2.50%)

At close: Aug 14, 2026

-22.00% (1Y)

Market Cap	6.64B -26.2%
Revenue (ttm)	6.40B -77.0%
Net Income	-4.60B
EPS	-107.95
Shares Out	42.59M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,457
Open	157.00
Previous Close	160.00
Day's Range	154.00 - 159.50
52-Week Range	116.00 - 357.00
Beta	0.01
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 25, 2026

About Instituto Rosenbusch

Instituto Rosenbusch S.A. manufactures and sells veterinary products in Argentina. The company offers biological products, including products for reproductive-respiratory complex, IBR, BVD, brucelosis, carbuncle, and other diseases; clostridial vaccines; vaccines for cattle, sheep, goats, horses, and dogs; and products for the prevention of pneumonia and calve diarrhea, and cattle infectious keratoconjunctivitis. It also provides pharmaceutical products, such as external and internal antiparasitics, endectocides, antimicotics-bacteriostatics, i... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1917

Country Argentina

Stock Exchange Buenos Aires Stock Exchange

Ticker Symbol ROSE

Full Company Profile

Financial Performance

In fiscal year 2026, Instituto Rosenbusch's revenue was 1.46 billion, a decrease of -77.27% compared to the previous year's 6.40 billion. Losses were -466.30 million, -89.86% less than in 2025.

Financial Statements